These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31301880)

  • 41. Is electroconvulsive therapy effective as augmentation in clozapine-resistant schizophrenia?
    Kittsteiner Manubens L; Lobos Urbina D; Aceituno D
    Medwave; 2016 Oct; 16(Suppl5):e6577. PubMed ID: 27813505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
    Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
    J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theta Burst Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations: Negative Findings From a Double-Blind-Randomized Trial.
    Koops S; van Dellen E; Schutte MJ; Nieuwdorp W; Neggers SF; Sommer IE
    Schizophr Bull; 2016 Jan; 42(1):250-7. PubMed ID: 26221051
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ECT and clozapine in schizophrenia.
    Fink M
    J ECT; 1998 Dec; 14(4):223-6. PubMed ID: 9871841
    [No Abstract]   [Full Text] [Related]  

  • 45. MRI-targeted repetitive transcranial magnetic stimulation of Heschl's gyrus for refractory auditory hallucinations.
    Blumberger DM; Christensen BK; Zipursky RB; Moller B; Chen R; Fitzgerald PB; Daskalakis ZJ
    Brain Stimul; 2012 Oct; 5(4):577-85. PubMed ID: 22410480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of cerebellar vermal deep high frequency (theta range) repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: A randomized rater blind-sham controlled study.
    Garg S; Sinha VK; Tikka SK; Mishra P; Goyal N
    Psychiatry Res; 2016 Sep; 243():413-20. PubMed ID: 27450744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exacerbation of auditory verbal hallucinations with adjunctive high-frequency cerebellar vermal repetitive transcranial magnetic stimulation in schizophrenia: a case report.
    Garg S; Goyal N; Tikka SK; Sinha VK
    J ECT; 2013 Mar; 29(1):65-6. PubMed ID: 23303419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Placebo Response in Repetitive Transcranial Magnetic Stimulation Trials of Treatment of Auditory Hallucinations in Schizophrenia: A Meta-Analysis.
    Dollfus S; Lecardeur L; Morello R; Etard O
    Schizophr Bull; 2016 Mar; 42(2):301-8. PubMed ID: 26089351
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clozapine-resistant schizophrenia: a positive approach.
    Williams L; Newton G; Roberts K; Finlayson S; Brabbins C
    Br J Psychiatry; 2002 Sep; 181():184-7. PubMed ID: 12204919
    [No Abstract]   [Full Text] [Related]  

  • 50. How to identify and manage non-response to clozapine?
    Shad MU; Felzien E; Roy K; Sethi S
    Asian J Psychiatr; 2019 Oct; 45():50-52. PubMed ID: 31494348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. rTMS as an add-on treatment for resistant obsessive-compulsive symptoms in patients with schizophrenia: report of three cases.
    Mendes-Filho VA; Belmonte-de-Abreu P; Pedrini M; Cachoeira CT; Lobato MI
    Braz J Psychiatry; 2013; 35(2):210-1. PubMed ID: 23904031
    [No Abstract]   [Full Text] [Related]  

  • 52. Efficacy of high-frequency repetitive transcranial magnetic stimulation on PANSS factors in schizophrenia with predominant negative symptoms - Results from an exploratory re-analysis.
    Hansbauer M; Wobrock T; Kunze B; Langguth B; Landgrebe M; Eichhammer P; Frank E; Cordes J; Wölwer W; Winterer G; Gaebel W; Hajak G; Ohmann C; Verde PE; Rietschel M; Ahmed R; Honer WG; Malchow B; Strube W; Schneider-Axmann T; Falkai P; Hasan A
    Psychiatry Res; 2018 May; 263():22-29. PubMed ID: 29482042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia.
    Poulet E; Brunelin J; Bediou B; Bation R; Forgeard L; Dalery J; d'Amato T; Saoud M
    Biol Psychiatry; 2005 Jan; 57(2):188-91. PubMed ID: 15652879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination.
    Moncrieff J
    Br J Psychiatry; 2003 Aug; 183():161-6. PubMed ID: 12893670
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Refractory schizophrenia: a neglected clinical problem.
    Borgio JG; Bressan RA; Barbosa Neto JB; Daltio CS
    Braz J Psychiatry; 2007 Sep; 29(3):292-3. PubMed ID: 17891263
    [No Abstract]   [Full Text] [Related]  

  • 56. Psychotherapy and psychopharmacology utilization following repetitive transcranial magnetic stimulation (rTMS) in patients with major depressive disorder.
    Needs P; Mote SD; Manocchia M; King JD; Szuba DD; Lustig SL; Shah VN
    Psychiatry Res; 2019 Aug; 278():51-55. PubMed ID: 31146141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis.
    Veerman SR; Schulte PF; Begemann MJ; Engelsbel F; de Haan L
    Pharmacopsychiatry; 2014 Sep; 47(6):185-94. PubMed ID: 25002291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful use of maintenance electroconvulsive therapy in the treatment of clozapine-associated obsessive-compulsive symptoms in schizophrenia: a case report.
    Rao NP; Antony A; Raveendranathan D; Venkatasubramanian G; Behere RV; Varambally SS; Gangadhar BN
    J ECT; 2011 Mar; 27(1):e37-8. PubMed ID: 20938347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
    Jiménez-Cornejo M; Munizaga G; Aceituno D
    Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relief from chronic intractable auditory hallucinations after long-term bilateral theta burst stimulation.
    Eberle MC; Wildgruber D; Wasserka B; Fallgatter AJ; Plewnia C
    Am J Psychiatry; 2010 Nov; 167(11):1410. PubMed ID: 21041260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.